Chennai, India

Sridhar Ramanathan Iyer

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Orchid Pharma Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sridhar Ramanathan Iyer. Retrieved from https://idiyas.com/inventor/sridhar-ramanathan-iyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **CARBAPENEM COMPOUNDS**

Introduction

Sridhar Ramanathan Iyer is an inventor known for his contributions to the field of pharmaceutical compounds. He has focused on developing carbapenem compounds that are particularly useful in treating bacterial infections, especially those that are drug-resistant. His work is significant in the ongoing battle against antibiotic resistance.

Latest Patents

Iyer's notable patent is titled "Carbapenem Compounds," with the international application number PCT/IN2017/000060. This patent was published under the Patent Cooperation Treaty (PCT) on September 21, 2017. The invention relates to carbapenem compounds, their stereoisomers, and pharmaceutically acceptable salts or N-oxides, which may be beneficial for treating bacterial infections.

Career Highlights

Throughout his career, Iyer has been involved in innovative research and development in the pharmaceutical industry. His work has contributed to advancements in antibiotic treatments, which are crucial for public health.

Collaborations

Iyer has collaborated with several notable individuals in his field, including Gopalan Balasubramanian and Maneesh Paul-Satyaseela. These collaborations have enhanced the research and development of his patented compounds.

Conclusion

Sridhar Ramanathan Iyer's work on carbapenem compounds represents a vital contribution to the pharmaceutical industry, particularly in addressing the challenges posed by drug-resistant bacterial infections. His innovative research continues to pave the way for new treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…